Activation of the interferon pathway in trophoblast cells productively infected with SARS-CoV-2.
暂无分享,去创建一个
S. Chanda | D. Pizzo | Laura Martin-Sancho | Morgan Meads | Francesca Soncin | Sampada Kallol | Omonigho Aisagbonhi | Robert Morey | R. Morey | M. Meads | O. Aisagbonhi
[1] S. Dietmann,et al. Stem-cell-derived trophoblast organoids model human placental development and susceptibility to emerging pathogens. , 2022, Cell stem cell.
[2] M. Diamond,et al. Innate immunity: the first line of defense against SARS-CoV-2 , 2022, Nature Immunology.
[3] H. Smits,et al. Microbiota and compartment matter in the COVID-19 response , 2021, Nature Immunology.
[4] L. Laurent,et al. Transcriptomic Drivers of Differentiation, Maturation, and Polyploidy in Human Extravillous Trophoblast , 2021, Frontiers in Cell and Developmental Biology.
[5] D. Roberts,et al. SPECIAL REPORT: A standardized definition of placental infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a consensus statement from the National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (NIH/NICHD) SARS-CoV-2 placen , 2021, American Journal of Obstetrics and Gynecology.
[6] M. Koopmans,et al. Unique Severe COVID-19 Placental Signature Independent of Severity of Clinical Maternal Symptoms , 2021, Viruses.
[7] Y. Mekki,et al. Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome , 2021, Placenta.
[8] G. Gao,et al. Cell entry by SARS-CoV-2 , 2021, Trends in Biochemical Sciences.
[9] F. Crispi,et al. Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise , 2021, Modern Pathology.
[10] J. Schultze,et al. COVID-19 and the human innate immune system , 2021, Cell.
[11] R. Redline,et al. Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus , 2021, Modern Pathology.
[12] M. Puri,et al. COVID-19 as an independent risk factor for subclinical placental dysfunction , 2021, European Journal of Obstetrics & Gynecology and Reproductive Biology.
[13] K. Mertz,et al. Placental Pathology Findings during and after SARS-CoV-2 Infection: Features of Villitis and Malperfusion , 2020, Pathobiology.
[14] L. Mofenson,et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis , 2020, BMJ.
[15] F. Kirchhoff,et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro , 2020, Nature Communications.
[16] Adam Hage,et al. TRIM Proteins in Host Defense and Viral Pathogenesis , 2020, Current Clinical Microbiology Reports.
[17] A. Iwasaki,et al. The Role of Immune Factors in Shaping Fetal Neurodevelopment. , 2020, Annual review of cell and developmental biology.
[18] M. Smithgall,et al. Third‐trimester placentas of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐positive women: histomorphology, including viral immunohistochemistry and in‐situ hybridization , 2020, Histopathology.
[19] N. Schmidt,et al. Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 , 2020, Frontiers in Immunology.
[20] Mohammed S. Alqahtani,et al. Targeting hub genes and pathways of innate immune response in COVID-19: A network biology perspective , 2020, International Journal of Biological Macromolecules.
[21] J. Goldstein,et al. Placental Pathology in COVID-19 , 2020, American journal of clinical pathology.
[22] A. Iwasaki,et al. Contributions of maternal and fetal antiviral immunity in congenital disease , 2020, Science.
[23] A. Spanevello,et al. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection , 2020, European Journal of Internal Medicine.
[24] Mandeep R. Mehra,et al. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal , 2020, The Journal of Heart and Lung Transplantation.
[25] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[26] Alireza Hadj Khodabakhshi,et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.
[27] B. Slobedman,et al. Interferon-Independent Upregulation of Interferon-Stimulated Genes during Human Cytomegalovirus Infection is Dependent on IRF3 Expression , 2019, Viruses.
[28] M. Suyama,et al. Derivation of Human Trophoblast Stem Cells. , 2018, Cell stem cell.
[29] J. Kwon,et al. Viral Infections During Pregnancy , 2015, American journal of reproductive immunology.
[30] R. Romero,et al. New Insights into the Relationship between Viral Infection and Pregnancy Complications , 2014, American journal of reproductive immunology.
[31] F. Arechavaleta-Velasco,et al. Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. , 2006, The American journal of pathology.